Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
Atkins
N S
NS
Lindo
J F
JF
Lee
M G
MG
Hanchard
B
B
Robinson
R D
RD
Bundy
D A
DA
D000276:Adjuvants, Immunologic; D000818:Animals; D000909:Antibodies, Helminth / Q000032:analysis; D000947:Antigens, Helminth / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D015481:HTLV-I Antibodies / Q000032:analysis; D015490:HTLV-I Infections / Q000150:complications / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D017171:Strongyloides stercoralis / Q000276:immunology*; D013322:Strongyloidiasis / Q000150:complications / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000909:Antibodies, Helminth; D000947:Antigens, Helminth; D015481:HTLV-I Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007073:Immunoglobulin E